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A novel, ﬂuorescent NAD derivative is processed as substrate by
three diﬀerent NAD-consuming enzymes. The new probe has
been used to monitor enzymatic activity in a continuous format
by changes in ﬂuorescence and, in one case, to directly visualize
alternative reaction pathways.
Nicotinamide adenine dinucleotide 1 (NAD, Fig. 1) is an
essential cofactor found in all living cells. NAD-dependent
enzymes are involved in many fundamental biological processes,
including energy metabolism, cell signaling, gene expression
and epigenetic control.1 They can be grouped into redox
enzymes, which draw on the reversible reduction/oxidation
of the nicotinamide fragment,2 and NAD-consuming enzymes
such as glycohydrolases, pyrophosphatases and ADP-ribosyl
transferases, which cleave one of the high-energy bonds in
NAD (i.e. the pyrophosphate or N-glycosidic bond).3 Individual
NAD-consuming enzymes have been identiﬁed as potent regulators
of key cellular functions such as calcium homeostasis and
DNA repair.3,4 Structural analogues of NAD are therefore
highly sought after as biochemical tools to study these enzymes
and processes.
To date, structural modiﬁcations of NAD have focused mostly
on the nicotinamide riboside and pyrophosphate moieties,5
while modiﬁcations on the adenine ring are relatively rare.6,7
One important example is 1,N6-etheno NAD 2 (e-NAD,
Fig. 1), a ﬂuorescent NAD derivative that has found very
wide application in biochemical assays for NAD-consuming
enzymes.7,8 These assays are based on the ﬂuorescence emission
of the 1,N6-etheno adenosine fragment, which in intact e-NAD
2 is internally quenched by the nicotinamide moiety.7,8
Chemical or enzymatic removal of the nicotinamide leads to
a ﬂuorescence signal that can be used to follow this reaction.
Although introduced in the early 1970s, 2 and its analogues
have remained as the only ﬂuorophores available for such
applications to date. However, 2 is an unsuitable substrate for
a number of important NAD-consuming enzymes,9 and its
chemical structure does not allow optimization of its enzymo-
logical or ﬂuorescence properties.
Herein, we describe a new family of NAD ﬂuorophores with
a ﬂuorogenic substituent in position 8 of the adenine base and
tunable ﬂuorescence properties (Fig. 1, 3a–e). We show that
the derivative with the most interesting ﬂuorescence characteristics,
3e, is recognized as a substrate by three diﬀerent NAD-consuming
enzymes and can be used to monitor enzyme activity in real time.
The new probe has unique practical utility as it allows, for the ﬁrst
time, direct visualisation of the diﬀerent reaction pathways of a
multi-functional ADP-ribosyl cyclase involved in cell signaling.
The 8-substituted NAD derivatives 3a–e were prepared from
the corresponding adenosine monophosphate (AMP) building
blocks 5a–e (Scheme 1).w The ﬂuorogenic substituent was intro-
duced at position 8 of AMP under aqueous Suzuki–Miyaura
conditions,6c,10 followed by MnCl2-catalyzed pyrophosphate
bond formation.11 Depending on the nature of the 8-substituent,
the NAD derivatives 3a–e showed variable ﬂuorescence character-
istics (Fig. S1 and Table S1, ESIw) with particularly pronounced
diﬀerences in the ﬂuorescence quantum yields F of individual
analogues (Table 1). Interestingly, ﬂuorescence in this series was
pH-dependent, with a sharp increase in emission between pH 3–6
for all dinucleotides apart from 3d (Fig. S2, ESIw). Above pH 6
ﬂuorescence remained stable, which is important with a view
towards potential biological applications, as the pH working
range of several NAD-dependent enzymes is between pH 7–8.
Fig. 1 Chemical structures of natural NAD 1, 1,N6-ethenoadenine
dinucleotide 2, and NAD derivatives 3a–e developed in this study.
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Importantly, when we compared the ﬂuorescence emission
of AMP/NAD pairs with the same 8-substituent, we found
that F was generally markedly higher for the AMP derivative
(Table 1). As previously described for 2,7,8 this observation
can be attributed to intramolecular ﬂuorescence quenching in
the case of the intact NAD derivatives due to the interaction of
the nicotinamide and substituted adenine rings. To test this
hypothesis, we subjected NAD derivatives 3a–e to chemical
hydrolysis under basic conditions, and followed these reactions
by ﬂuorimetry. As expected, ﬂuorescence emission increased
signiﬁcantly upon hydrolytic removal of the nicotinamide ring
(Fig. S3 and S4, ESIw), due to the abolition of the internal
quenching eﬀect. The hydrolytic degradation into the corres-
ponding ADPR (adenosine diphosphate ribose) and nicotinamide
was also conﬁrmed in HPLC control experiments with 3e
(Fig. S5, ESIw). This NAD derivative showed by far the strongest
ﬂuorescence increase, as expected from the considerable diﬀer-
ence in quantum yields between 3e and 5e (Table 1). Signiﬁcantly,
while for most 8-substituted AMP/NAD pairs the ﬂuorescence
emission ratio F5/F3 is in the same range as for e-AMP/e-NAD,
for 5e/3e this ratio is up to 7-fold greater than reported values for
Fe-AMP/Fe-NAD. We speculated that this could allow for a more
sensitive ﬂuorescence-based assay of NAD-consuming enzymes
than is possible with 2. 3e would be particularly attractive for
such applications as its lex and lem do not interfere with the
intrinsic ﬂuorescence of most proteins (Fig. S6, ESIw).
In order to assess the suitability of 3e as a non-natural substrate
for NAD-consuming enzymes, we chose three commercially
available enzymes—nucleotide pyrophosphatase (NPP) from
Crotalus adamanteus venom,12 NAD-glycohydrolase (NGH)
from porcine brain,13 and ADP-ribosyl cyclase (ADPRC)
from Aplysia californica14—which catalyse diﬀerent covalent
modiﬁcations of NAD (Scheme S1, ESIw). Following the
consumption of 3e and the formation of the respective reaction
product for each enzyme by HPLC, we found that, pleasingly,
all three enzymes use 3e as a substrate (Fig. S7–S9, ESIw).
Next, we investigated if the progress of these enzyme reactions
could be monitored by ﬂuorimetry. As expected, the consumption
of 3e by NPP led to a progressive increase in ﬂuorescence
which could be followed in a continuous assay format (Fig. 2).
Similar results were obtained with NGH (Fig. S10, ESIw),
although the limited aqueous solubility of this membrane-bound
enzyme13 complicated the in situ monitoring of the reaction
and necessitated an additional pipetting step.
With NPP, we used the continuous assay for the enzymo-
logical characterization of 3e. After conﬁrming the linearity of
the ﬂuorescence response across a range of concentrations for
both 3e and its enzymatic product 5e, we found that the initial
reaction velocities were proportional to the enzyme concen-
tration (Fig. S11 and S12, ESIw). Having established a suitable
enzyme/substrate ratio, the substrate concentration was varied
to generate a saturation curve for the determination of the Km
value of 3e. The variation of the initial velocity with the
concentration of 3e was well described by the Michaelis–Menten
equation and Hanes–Woolf plots, resulting in Km of 6.22 
3.08 mM and vmax of 0.0530  0.0140 mmol min1 mg1
(Fig. S13, ESIw). This Km value for 3e is comparable to literature
values for NAD with several pyrophosphatases.12 In contrast,
the frequently used ﬂuorophore 2 and its derivative e-PdAD have
often higher Km values (Table S2, ESIw).
12 This may be due to
interference of the etheno bridge in 2 with hydrogen bonding of
the pyrimidine ring at the cofactor binding site. Substitution in
position 8 in 3e, on the other hand, does not perturb hydrogen
bond formation. These results therefore suggest that, at least for
NPP, the new ﬂuorophore 3e is a closer model of the natural
cofactor NAD than 2.
Finally, we studied the behavior of 3e towards the multi-
functional enzyme ADP-ribosyl cyclase (ADPRC).14 ADPRC
catalyzes primarily the cyclization of NAD at the N1 position to
give N1-cADPR (cyclic adenosine diphosphate ribose), but also
the hydrolysis of N1-cADPR into ADPR (Scheme S2, ESIw).14a
N1-cADPR is an important 2nd messenger and mediator of
Scheme 1 Reagents and conditions: (i) Na2PdCl4, TPPTS, R-B(OH)2,
K2CO3, H2O, D, 1–24 h; (ii) morpholine, dipyridyldisulﬁde, Ph3P, DMSO,
rt, 2 h; (iii) b-NMN, dry MgSO4, MnCl2 0.2 M in formamide, rt, 24 h.
Table 1 Quantum yields of NAD (3) and AMP (5) derivatives
in water
Cmpd R F3 F5 F5/F3
2 Not applicable 0.028–0.09a 0.56–0.59a 6–20
ab 3-Pyridinyl 0.003 0.003 1
bb Phenyl 0.207 0.669 B3
cb 3-(Boc-aminomethyl)phenyl 0.150 0.888 B6
db 2,4-DMT-pyrimidinyl 0.003 0.021 7
eb 2-Pyrrolyl 0.005 0.231 B46
a Values from ref. 7, 8 and 12b. b 3 or 5, for scaﬀolds see Scheme 1.
Fig. 2 Fluorimetric nucleotide pyrophosphatase assay of 3e.Conditions:
0.007 U mL1 enzyme, 3e (0.2–6.5 mM) in 10 mMMgCl2, 50 mM Tris/
HCl (pH 8), 30 1C, lex = 300 nm, lem = 410 nm, gain 15%. Enzyme
addition at 400 s. Positive control (3 mM 5e) and negative control
(buﬀer) included.
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IP3-independent calcium signaling,
15 and structural analogues of
N1-cADPR are sought after as biological tools.16 Evidently, the
natural N1-cyclization of ADPRC is not possible in the case of
the existing ﬂuorophore 2, due to the presence of the etheno
bridge. Instead, 2 redirects ADPRC activity, giving rise to a non-
natural, ﬂuorescent derivative cyclized at N7.14b
Upon incubation of 3e at either 19.2 mM or 9.6 mM with
ADPRC at 0.025 U mL1, we observed a decrease in ﬂuores-
cence (Fig. 3 and Fig. S14, ESIw, blue lines). This result
suggests that, like NAD, 3e is indeed cyclized at N1, giving
rise to 8-(pyrrol-2-yl) N1-cADPR, as cyclization at N7 would
be expected to lead to an increase, not a decrease in ﬂuores-
cence. Using this decrease in ﬂuorescence to determine the
enzymological parameters of 3e for the cyclase activity of
ADPRC, we obtained Km of 74  28 mM and vmax of 21.80 
4.11 mmol min1 mg1 (Fig. S15–S17, ESIw). ThisKm value of 3e
is in the same range as literature values for the natural substrate
NAD, in contrast to 2 and other N7-cyclised dinucleotide
substrates of ADPRC, for which signiﬁcantly lower Km values
have been reported (Table S3, ESIw).
Interestingly, when the same experiments were carried out at a
higher concentration of ADPRC, ﬂuorescence emission increased
again after the initial drop (Fig. 3 and Fig. S14, ESIw, red lines). It
is known that the N1-cADPR-hydrolase activity of ADPRC is
only unmasked at high enzyme concentrations.14a It therefore
appears that under these conditions, ADPRC initially cyclizes 3e
into 8-pyrrolyl N1-cADPR, before hydrolysing the latter into the
linear, and ﬂuorescent, 8-pyrrolyl ADPR (Scheme S2, ESIw). This
interpretation is in keeping with previous mechanistic studies on
the diﬀerent activities of ADPRC.14a Thus, the new ﬂuorophore
3e allows, for the ﬁrst time, the direct visualization of the diﬀerent
reaction pathways of ADPRC, which makes it a unique tool for
biological studies on this enzyme and its role in cell signalling.
In summary, we have developed a new type of ﬂuorescent
NAD derivative with a ﬂuorogenic substituent in position 8 of
the adenine base. We show that a speciﬁc analogue in this
series, 3e, is recognized as a substrate by three diﬀerent NAD-
dependent enzymes. Furthermore, 3e can be used to monitor
enzyme activity in continuous form and, in the case of
ADPRC, to visualize diﬀerent reaction pathways. Compared
to the existing probe 2, the new ﬂuorophore oﬀers signiﬁcant
advantages in terms of its enzymological and ﬂuorescence
properties, and the breadth of its applicability is the subject
of ongoing studies.
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